FDA Inspection 1319250 — NeuroMetrix, Inc.

NeuroMetrix, Inc. — FEI 3011412151

The FDA completed an inspection of NeuroMetrix, Inc. on May 27, 2026 in Rockaway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 27, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Rockaway, NJ (United States)

Citations

IDCFRDescription
23088ISO 13485:2016 Clause 7.1Records of risk management activities in product realization not maintained
23114ISO 13485:2016 Clause 7.3.6Design and development verification not performed
23216ISO 13485:2016 Clause 8.2.2Lack of documented justification for not investigating complaint(s)
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.